On the heels of pulmonary arterial hypertension drug nod, Merck launches 'Outnumber PAH' campaign
Mere weeks after earning the FDA’s signoff on the new drug Winrevair to treat pulmonary arte…
Mere weeks after earning the FDA’s signoff on the new drug Winrevair to treat pulmonary arte…